We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
新型双重激动剂Survodutide在无糖尿病的肥胖患者中实现了13%的体重减轻。了解该药物的作用机制、副作用及前景。
